The urokinase-type plasminogen activator (UPA) and its receptor are expressed in the vasculature and are involved in cell migration and remodeling of the extracellular matrix in the neointima. Vessels with atherosclerosis or neointimal hyperplasia, when compared with normal vessels, contain high UPA activity as well as increased levels of UPA receptor. In this study, we have identified the stimulation of vascular smooth muscle cell proliferation as a novel activity for UPA in the vessel wall. High-molecular-weight-UPA (12-200 nmol/L range) stimulated DNA synthesis and cell proliferation, which was half that induced by fetal calf serum or by platelet-derived growth factor-BB. UPA did not induce growth of endothelial cells, and tissue-type plasminogen activator showed no activity on either cell type. Induction of proliferation required the complete UPA molecule but was independent of the proteolytic activity of UPA, whereas neither the amino-terminal fragment nor the catalytic domain by itself was mitogenic. UPA also stimulated c-fos/c-myc mRNA expression and mitogen-activated protein kinase activity in smooth muscle cells. Blocking monoclonal antibodies against the UPA receptor and the enzymatic removal of receptors were ineffective in inhibiting the mitogenic effect of UPA, suggesting a UPA receptor-independent mechanism. Thus, we provide evidence for a novel function of UPA on vascular smooth muscle cell proliferation that, together with its previously documented involvement in regulating pericellular proteolysis-related events and cell migration, provides additional evidence for a role in the pathogenesis of atherosclerosis/restenosis.
The adhesion protein vitronectin is associated with extracellular matrices and serves as cofactor for plasminogen-activator inhibitor-1 . Limited proteolysis by plasmin converts vitronectin into defined fragments which are detectable at sites of intlammation and angiogenesis. The loss and gain of binding functions of vitronectin fragments for macromolecular ligands was characterized in the present study. The initially generated 61 -63-kDa vitronectin-( 1 -348)-fragment serves as typical binding component for plasminogen and binding function was lost upon carboxypeptidase B treatment indicating the importance of a C-terminal lysine. Complementary binding sites reside in isolated plasminogen kringles 1-3 (designated angiostatin) as deduced from direct binding and ligand blotting experiments. A synthetic vitronectin-(331 -348)-peptide from the C-terminus of the 61 -63-kDa fragment could mimic plasminogen and angiostatin binding. Also, the immobilized peptide bound tissue plasminogen-activator and mediated plasmin formation, comparable to fibrinogen-derived peptides. The 61 -63-kDa vitronectin fragment was indistinguishable in its adhesive properties to intact vitronectin and bound active but not latent plasminogen-activator inhibitor-1 . Late plasminolysis of vitronectin resulted in the processing of the N-terminal region of the protein with the generation of 42 kDd3S-kDa fragments that had GIy89 as new N-terminus and that were ineffective in promoting cell adhesion. Thus, at sites of cell-matrix interactions which become proteolytically modified by plasmin during inflammatory and angiogenic processes, vitronectin serves as plasminogedangiostatin-binding factor. Due to this differential change in functions particularly at sites of deposition in the vascular system or at wound sites vitronectin is considered to be an important morpho-regulatory factor.Keywords: angiostatin ; plasmin ; vitronectin; adhesion ; proteolysis.The molecular dynamics in stabilization and destabilization of cellular contacts is under strict control in many biological systems as diverse as embryo implantation, histogenesis, angiogenesis, cellular extravasation or tumor metastasis [ 11. Cell-specific hydrolytic enzymes and the plasminogen-activation system have been implicated in many instances as modulators of the cell-matrix micro-environment. Thus, cell migration, invasion and cell proliferation rely on a proteolytic/anti-proteolytic balance based on cell-surface-restricted reactions. In particular, cell surface receptors for urokinase [2], tissue plasminogen activator 131 or cellular binding sites for plasminogen [4] are positioned for localized generation of plasmin. The early phase of plasminogen activation is controlled by several serine protease inhibitors of which extracellular matrix-associated plasminogen-activator inhibitor-1 appears to be the predominant one [S]. The multifunctional adhesive protein vitronectin serves as binding and stabilization factor for plasminogen-activator inhibitor-1 [6 -XI, and colocalization of both compo...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.